Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced that its board of directors has elected John Paulson to serve as a director, effective June 14, …
Prominent hedge fund manager James E. Flynn of the Deerfield Management fund has indicated a bullish outlook towards two controversial healthcare stocks in …
Cantor analyst Louise Chen is out with initiation reports assessing Valeant Pharmaceuticals Intl Inc (NYSE:VRX) with more confidence than the rest of the Street’s …
by David Goodboy Bill Miller is back on a winning streak. Once a hero of Wall Street with an enviable record of 15 …
Israel “Izzy” Englander is a self-made man living the American dream, whose Polish parents have since seen their son carve out a small …
Canaccord analysts are out with neutral standpoints on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Endo International plc (NASDAQ:ENDP). However, while one analyst sees …
Today, shareholders of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) woke up to a nice 7% pop in the value of their shares, after the …
Rob Citrone is fund manager of the $5.37 billion Discovery Capital Management fund.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a difficult stock to value. Unlike a ‘regular’ company with a stock price reflecting cash flow, EPS, …
Anthony Rizza became a part of the team at Columbus Circle Investors (CCI) in the summer of 1991, and since then has gone on …
